TUNG ROGER D (Chief Executive Officer) sold 1.4% of their position (13.48K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $41.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/16/2022ACC: 0001209191-22-010075
DirectorOfficer· Chief Executive Officer
Since Jan 2019
-13.48K
Net shares
Net seller
$41.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.48K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.48K
Price / share
$3.09
Trade value
$41.65K
% of position
1.4%
2/15/2022
993.74K→980.26K
Total
Net shares
−13.48K
Net value
-$41.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2022 | S · Sale | −13.48K | $3.09 | $41.65K | 1.4% | 993.74K | 980.26K |
| Total | −13.48K | -$41.65K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned121.87K
Common Stock
IndirectShares owned12.39K
Common Stock
IndirectShares owned13.27K
Total
147.54K indirect147.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 121.87K | Indirect |
| Common Stock | 12.39K | Indirect |
| Common Stock | 13.27K | Indirect |
| Total | 147.54K | 147.54K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported